Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 112 | -27 | -40 | -32 | -41 |
| Other Working Capital | -501 | 544 | -162 | 253 | 7 |
| Other Operating Activity | -2,473 | -4,163 | -4,749 | -2,611 | -2,938 |
| Operating Cash Flow | $-2,862 | $-3,645 | $-4,951 | $-2,390 | $-2,973 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 0 | 0 | -39 |
| Other Financing Activity | 12 | 2 | 118 | -10 | -506 |
| Financing Cash Flow | $12 | $2 | $118 | $-10 | $-546 |
| Exchange Rate Effect | 23 | -7 | 191 | 152 | 75 |
| Beginning Cash Position | 11,468 | 15,119 | 19,760 | 22,007 | 25,450 |
| End Cash Position | 8,641 | 11,468 | 15,119 | 19,760 | 22,007 |
| Net Cash Flow | $-2,850 | $-3,644 | $-4,833 | $-2,399 | $-3,518 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,862 | -3,645 | -4,951 | -2,390 | -2,973 |
| Free Cash Flow | -2,862 | -3,645 | -4,951 | -2,390 | -2,973 |